#USA #Addison, Texas #FX Shoulder Solutions #FX V135 #Easytech Shoulder

Groundbreaking Approval for FX V135® Easytech Shoulder System

On May 5, 2026, FX Shoulder Solutions, Inc. announced a significant accomplishment in medical device innovation: the receipt of FDA 510(k) clearance for the FX V135® Easytech Shoulder System. This advanced system serves as the next generation of stemless shoulder arthroplasty implants, providing a unique design that supports both stemless and modular stem options for surgeons during procedures.

As the demand for shoulder arthroplasty continues to grow, the FX V135® Easytech has been developed to meet the needs of surgeons and patients alike. The system enables clinicians to start with a stemless solution, transitioning if necessary to a short stem during surgery—without the need for additional instrumentation or an entirely different system. This flexibility streamlines the surgical process and enhances the surgeons' ability to customize procedures based on individual patient anatomy and needs.

Details of the FX V135® Easytech System

The FX V135® Easytech stands out as the only system on the U.S. market that integrates a stemless anchor base with a removable anatomic stem adaptation within a single humeral platform. The system is offered in both an anatomic configuration as a stemless solution with a short stem conversion option and a reverse configuration featuring a short stem. Additionally, the platform supports a variety of anchor base sizes ranging from 32mm to 44mm, and the humeral stem has an 8mm diameter, seamlessly compatible with previously cleared humeral head and glenoid options.

This advanced system is engineered for enhanced precision, featuring centered humeral cup tapers that optimize stability. Notably, the FX V135® Easytech introduces a +1mm humeral cup option, allowing for greater intraoperative fine-tuning of soft tissue tensioning, which is crucial for patient outcomes.

Commitment to Innovation and Efficiency

Baptiste Martin, CEO of FX Shoulder Solutions, expressed that this regulatory clearance is a vital milestone towards simplifying complexities in surgical procedures without limiting the choices available to surgeons. He emphasized that the FX V135® Easytech enables real-time adaptability during surgery, allowing for efficient, uncomplicated transitions from stemless to stemmed fixation—all contained within a single tray that aligns with the growing trend toward outpatient surgical center adaptations.

The FX V135® Easytech is a testament to FX Shoulder Solutions' ongoing dedication to purposeful innovation. This commitment has distinguished the company since its inception, focusing solely on shoulder arthroplasty with a mission to improve surgical outcomes through thoughtful design.

The Future of Shoulder Arthroplasty

The introduction of the FX V135® Easytech Shoulder System further solidifies FX Shoulder Solutions' position in the rapidly evolving field of shoulder arthroplasty. This platform not only encompasses stemless options but also addresses primary, fracture, and revision solutions, promoting a foundation of efficiency and adaptability during surgical procedures.

As the healthcare industry demands more innovative solutions, FX Shoulder Solutions will continue to advance its offerings based on feedback from surgeons. By innovating within the realm of shoulder arthroplasty, the company is positioned to improve overall surgical outcomes, ensuring both clinicians and patients benefit from cutting-edge medical technology.

For more information on FX Shoulder Solutions and their latest offerings, visit www.fxshouldersolutions.com.

Contact information for further inquiries:

• - Phone: 1-800-280-0775
• - Fax: 1-800-429-8965
• - Email: [email protected]